Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The C-terminal region of <i>Opisthorchis viverrini</i> granulin-1 promotes cell proliferation in the absence of regular secondary structure.

Australian journal of chemistry·2026

Same author

Transcriptional profiling of the Crocodylus porosus liver cell response to Kunjin virus reveal novel insights into the host-virus interface.

Microbial pathogenesis·2026

Same author

A novel hookworm vaccine candidate identified through immunomic profiling of human protective immunity.

International journal for parasitology·2026

Same author

Transgenic hookworm secretes anti-tetrodotoxin human single chain antibody.

Nature communications·2026

Same author

Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasis.

PLoS neglected tropical diseases·2026

Same author

Optimized hookworm-derived biologic, AIP-2<sub>NTQ48</sub> restores mucosal tolerance and down-regulates colon cancer-associated gene expression in TNBS-induced colitis.

Mucosal immunology·2026

Search research articles

Related Experiment Video

Updated: May 16, 2026

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Published on: April 6, 2015

The hookworm pharmacopoeia for inflammatory diseases.

Severine Navarro¹, Ivana Ferreira, Alex Loukas

¹Center for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, James Cook University, Cairns, Australia.

International Journal for Parasitology

|December 11, 2012

Summary

Hookworm infections may prevent allergic asthma and inflammatory bowel diseases by conditioning the immune system. Hookworm proteins show potential as novel anti-inflammatory therapies for these chronic conditions.

More Related Videos

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

Related Experiment Videos

Last Updated: May 16, 2026

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Published on: April 6, 2015

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

Area of Science:

Immunology
Parasitology
Gastroenterology

Background:

Declining parasitic infections in developed nations correlate with rising allergic and autoimmune diseases.
Current treatments for chronic inflammatory conditions offer limited efficacy, highlighting an unmet need for novel anti-inflammatory strategies.
Existing therapeutic targets for allergic and autoimmune pathways have shown limited success.

Purpose of the Study:

To explore the immunomodulatory benefits of hookworm infections in preventing allergic asthma and inflammatory bowel diseases.
To investigate the therapeutic potential of hookworm-derived proteins in models of inflammation.
To identify novel avenues for controlling and reversing pathological processes in allergic and inflammatory bowel diseases.

Main Methods:

Review of existing literature on parasitic infections and immune system conditioning.
Examination of immunomodulatory properties of specific hookworm-derived proteins.
Analysis of these proteins in established models of allergic asthma and inflammatory bowel disease.

Main Results:

Hookworm infections demonstrate an ability to condition the immune system, potentially preventing allergic asthma and inflammatory bowel diseases.
Selected hookworm-derived proteins exhibit significant immunomodulatory properties.
The study identifies specific proteins and their mechanisms for immune system modulation.

Conclusions:

Hookworm infection offers a potential protective mechanism against allergic and autoimmune disorders.
Hookworm-derived proteins represent a promising therapeutic strategy for inflammatory conditions.
Further research into these proteins could lead to effective treatments for allergic asthma and inflammatory bowel diseases.